2018
DOI: 10.3390/medsci6040113
|View full text |Cite
|
Sign up to set email alerts
|

New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins

Abstract: Bladder cancer is the 10th-most common cancer worldwide. The diagnosis and follow-up of patients require costly invasive methods and due to these expenses, bladder cancer continues to be one of the expensive malignancies. Early diagnosis is crucial in bladder cancer as it is in other cancers; therefore, non-invasive biomarkers for early diagnosis are very important. In this review, we aimed to focus on the most recent investigations on potential urinary micro RNA (miRNA) and protein biomarkers for bladder canc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
17
0

Year Published

2019
2019
2025
2025

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 86 publications
0
17
0
Order By: Relevance
“…Other miRNAs with an altered expression level in bladder cancer involved in EMT and invasion is miR-141. In multiple other pathologies [30], not only bladder cancer [31], miR-200c and miR-141 were considered prognostic markers [32]. It should be noted that for the range of bladder cancer samples studied, the expression levels of miR-205 and miR-200c are highly disputed [22, 33, 34], often reported as both downregulated [35] and overexpressed [17].…”
Section: Discussionmentioning
confidence: 99%
“…Other miRNAs with an altered expression level in bladder cancer involved in EMT and invasion is miR-141. In multiple other pathologies [30], not only bladder cancer [31], miR-200c and miR-141 were considered prognostic markers [32]. It should be noted that for the range of bladder cancer samples studied, the expression levels of miR-205 and miR-200c are highly disputed [22, 33, 34], often reported as both downregulated [35] and overexpressed [17].…”
Section: Discussionmentioning
confidence: 99%
“…Along with the aging population and the increasing age of surgical patients, the issue of perioperative complications and its costs gains importance (15). Despite the developing technologies, follow-up, and treatment of patients with invasive methods, bladder cancer still continues to be one of the expensive malignancies (16). There are relatively few articles on bibliometric analysis of urologic disorders; and one in bladder cancer.…”
Section: Discussionmentioning
confidence: 99%
“…These last two techniques are routinely used as follow-up methods. As a consequence, novel non-invasive biomarkers are being explored to early and accurately diagnose and monitor BC patients in order to avoid the performance of this aggressive technique while reaching or even exceeding the sensitivity and specificity of cystoscopy [6]. Urine represents the most accessible source of biological markers for the analysis of BC and other urological tumors since it is rapid and easily obtained by the patient, avoids patient discomfort and potential complications from an invasive procedure, is available in copious amounts and re-sampling is easily achievable [7].…”
Section: Introductionmentioning
confidence: 99%